Nuvo
As of the edition of 20 October 2026, Nuvo runs 2 drugs, 2 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
Nuvo was renamed in 2016.
- Nuvo Research Inc.: renamed in 2016
Drugs by status
| Status | Count |
|---|---|
| Marketed | 2 |
| Total | 2 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Diclofenac | none listed | 7 |
| Tetrachlorodecaoxide anhydrous | none listed | 0 |
A route B row is one company at one target.
Where its trials are
- Ear, nose and throat: 1 trials led
- Immune system: 1 trials led
- Lungs and airways: 1 trials led